ES8705384A1 - Procedimiento para preparar isomeros de derivados de prostaglandina - Google Patents

Procedimiento para preparar isomeros de derivados de prostaglandina

Info

Publication number
ES8705384A1
ES8705384A1 ES552553A ES552553A ES8705384A1 ES 8705384 A1 ES8705384 A1 ES 8705384A1 ES 552553 A ES552553 A ES 552553A ES 552553 A ES552553 A ES 552553A ES 8705384 A1 ES8705384 A1 ES 8705384A1
Authority
ES
Spain
Prior art keywords
procedure
formula
prostaglandin derivatives
isomers
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES552553A
Other languages
English (en)
Other versions
ES552553A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of ES8705384A1 publication Critical patent/ES8705384A1/es
Publication of ES552553A0 publication Critical patent/ES552553A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Emergency Protection Circuit Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE PROSTAGLANDINA DE FORMULA (I), DE SUS ISOMEROS, SALES NO TOXICAS Y CLATRATOS DE CICLODEXTRINA. COMPRENDE LA REACCION DE HIDROLISIS DE UN COMPUESTO DE FORMULA (II) O (III) PARA FORMAR UN COMPUESTO DE FORMULA (I), EN LAS QUE A, B, R1, R10, R11 Y R12 PUEDEN SER VARIOS TIPOS DE RADICALES Y N VALE 0-2. LA HIDROLISIS SE EFECTUA EN MEDIO ACUOSO ACIDO, A UNA TEMPERATURA COMPRENDIDA ENTRE LA AMBIENTE Y 70JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE HIPERTENSION, TROMBOSIS, ASMA, ULCERAS GASTRICAS Y COMO DIURETICOS.
ES552553A 1984-07-23 1986-02-28 Procedimiento para preparar isomeros de derivados de prostaglandina Expired ES8705384A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59151369A JPS6130554A (ja) 1984-07-23 1984-07-23 プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤

Publications (2)

Publication Number Publication Date
ES8705384A1 true ES8705384A1 (es) 1987-05-01
ES552553A0 ES552553A0 (es) 1987-05-01

Family

ID=15517042

Family Applications (3)

Application Number Title Priority Date Filing Date
ES545457A Expired ES8609232A1 (es) 1984-07-23 1985-07-22 Procedimiento para la preparacion de un analogo a la prosta-glandina
ES552553A Expired ES8705384A1 (es) 1984-07-23 1986-02-28 Procedimiento para preparar isomeros de derivados de prostaglandina
ES552554A Expired ES8705385A1 (es) 1984-07-23 1986-02-28 Procedimiento para preparar isomeros de derivados de prostaglandina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES545457A Expired ES8609232A1 (es) 1984-07-23 1985-07-22 Procedimiento para la preparacion de un analogo a la prosta-glandina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES552554A Expired ES8705385A1 (es) 1984-07-23 1986-02-28 Procedimiento para preparar isomeros de derivados de prostaglandina

Country Status (17)

Country Link
US (2) US4935446A (es)
EP (1) EP0196380B1 (es)
JP (1) JPS6130554A (es)
KR (1) KR860001119A (es)
AT (1) ATE67484T1 (es)
AU (1) AU596947B2 (es)
CA (1) CA1264320A (es)
DE (1) DE3584158D1 (es)
DK (1) DK333385A (es)
ES (3) ES8609232A1 (es)
FI (1) FI852856A7 (es)
GR (1) GR851812B (es)
HU (1) HU199781B (es)
NO (1) NO852916L (es)
PT (1) PT80848B (es)
YU (3) YU45985B (es)
ZA (1) ZA855533B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2192395B (en) * 1986-07-08 1990-11-14 Kotobuki Seiyaku Co Ltd Carbacyclin derivatives
US5218139A (en) * 1990-12-27 1993-06-08 G. D. Searle & Co. Method for inhibiting IgE production
US5148032A (en) * 1991-06-28 1992-09-15 Siemens Medical Laboratories, Inc. Radiation emitting device with moveable aperture plate
US5235816A (en) * 1991-10-10 1993-08-17 Praxair Technology, Inc. Cryogenic rectification system for producing high purity oxygen
MY144968A (en) 2005-04-11 2011-11-30 Xenon Pharmaceuticals Inc Spiro-oxindole compounds and their uses as therapeutic agents
AR053710A1 (es) * 2005-04-11 2007-05-16 Xenon Pharmaceuticals Inc Compuestos espiroheterociclicos y sus usos como agentes terapeuticos
EP3205644A1 (en) 2005-12-29 2017-08-16 Celtaxsys Inc. Diamine derivatives as inhibitors of leukotriene a4 hydrolase
WO2008046049A1 (en) * 2006-10-12 2008-04-17 Xenon Pharmaceuticals Inc. Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
EP2073806B1 (en) 2006-10-12 2012-02-15 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
WO2010045197A1 (en) * 2008-10-17 2010-04-22 Xenon Pharmaceuticals, Inc. Spiro-oxindole compounds and their use as therapeutic agents
HRP20150882T1 (hr) * 2008-10-17 2015-09-25 Xenon Pharmaceuticals Inc. Spirooksindolski spojevi i njihova upotreba kao terapijska sredstva
AR077252A1 (es) 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
PE20170202A1 (es) 2009-10-14 2017-03-24 Xenon Pharmaceuticals Inc Metodos sinteticos para compuestos espiro-oxoindol
US20110086899A1 (en) * 2009-10-14 2011-04-14 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
RU2596488C2 (ru) 2010-02-26 2016-09-10 Ксенон Фармасьютикалз Инк. Фармацевтические композиции спиро-оксиндольного соединения для местного введения и их применение в качестве терапевтических агентов
KR20150002794A (ko) 2012-04-12 2015-01-07 제논 파마슈티칼스 인크. 치료제로서 유용한 스파이로-옥시인돌 화합물을 위한 비대칭적 합성
AU2014240042C1 (en) 2013-03-14 2019-09-05 Celltaxis, Llc Inhibitors of leukotriene A4 hydrolase
AR103636A1 (es) 2015-02-05 2017-05-24 Teva Pharmaceuticals Int Gmbh Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol
WO2017218920A1 (en) 2016-06-16 2017-12-21 Teva Pharmaceuticals International Gmbh Asymmetric synthesis of funapide
CA3045887A1 (en) 2016-12-09 2018-06-14 Celtaxsys, Inc. Pendant amines and derivatives as inhibitors of leukotriene a4 hydrolase
US10202362B2 (en) 2016-12-09 2019-02-12 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
WO2018107158A1 (en) 2016-12-09 2018-06-14 Celtaxsys, Inc. Monamine and monoamine derivatives as inhibitors of leukotriene a4 hydrolase

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087620A (en) * 1975-07-17 1978-05-02 Ono Pharmaceutical Company 15-Cycloalkyl-prostaglandin derivatives
US4180675A (en) * 1975-07-17 1979-12-25 Warner-Lambert Company 15-Cycloalkyl-prostaglandin derivatives
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53103464A (en) * 1977-02-21 1978-09-08 Ono Pharmaceut Co Ltd Prostaglandin x analogues and process for their preparation
JPS53127441A (en) * 1977-04-11 1978-11-07 Ono Pharmaceut Co Ltd Prostaglandin-like compounds and their preparation
GB1588196A (en) * 1977-06-14 1981-04-15 Ono Pharmaceutical Co Prostaglandin analogues
JPS6022710B2 (ja) * 1977-09-16 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
JPS54125653A (en) * 1978-03-18 1979-09-29 Ono Pharmaceut Co Ltd Prostaglandin i2 analog, its preparation, and drug composition comprising it as active constituent
DE2912409A1 (de) * 1978-03-31 1979-10-11 Ono Pharmaceutical Co 6,9-methano-pgi tief 2 -analoge
JPS54130543A (en) * 1978-03-31 1979-10-09 Ono Pharmaceut Co Ltd Prostagladin i2 analog, and its preparation
US4220795A (en) * 1978-08-14 1980-09-02 Miles Laboratories, Inc. Cyclobutyl substituted derivatives of prostaglandin analogs
DE2902809A1 (de) * 1979-01-25 1980-08-07 Hoechst Ag Neue analoga von prostacyclin
DE3006865A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Hetero-imino-prostacycline
JPS58164512A (ja) * 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS591463A (ja) * 1982-06-28 1984-01-06 Ono Pharmaceut Co Ltd 新規なプロスタグランジンｄ類似化合物
JPS5944340A (ja) * 1982-09-08 1984-03-12 Sankyo Co Ltd メタノプロスタサイクリン誘導体の光学活性結晶性アミン塩およびその製法
JPS59163365A (ja) * 1983-03-08 1984-09-14 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物

Also Published As

Publication number Publication date
FI852856L (fi) 1986-01-24
ES545457A0 (es) 1986-09-01
JPS6130554A (ja) 1986-02-12
YU143387A (en) 1988-04-30
YU45985B (sh) 1992-12-21
GR851812B (es) 1985-11-26
CA1264320A (en) 1990-01-09
KR860001119A (ko) 1986-02-22
EP0196380A3 (en) 1987-07-01
US5109021A (en) 1992-04-28
AU4523285A (en) 1986-01-30
FI852856A0 (fi) 1985-07-22
HU199781B (en) 1990-03-28
US4935446A (en) 1990-06-19
AU596947B2 (en) 1990-05-24
EP0196380A2 (en) 1986-10-08
ES8705385A1 (es) 1987-05-01
ATE67484T1 (de) 1991-10-15
ES552553A0 (es) 1987-05-01
DE3584158D1 (de) 1991-10-24
NO852916L (no) 1986-01-24
ZA855533B (en) 1986-03-26
YU143287A (en) 1988-04-30
PT80848B (pt) 1987-11-30
ES8609232A1 (es) 1986-09-01
YU120185A (en) 1988-04-30
DK333385A (da) 1986-01-24
EP0196380B1 (en) 1991-09-18
FI852856A7 (fi) 1986-01-24
PT80848A (en) 1985-08-01
YU46220B (sh) 1993-05-28
ES552554A0 (es) 1987-05-01
YU46219B (sh) 1993-05-28
HUT39157A (en) 1986-08-28
DK333385D0 (da) 1985-07-22

Similar Documents

Publication Publication Date Title
ES8705385A1 (es) Procedimiento para preparar isomeros de derivados de prostaglandina
ES8603863A1 (es) Un procedimiento para la preparacion de agentes inotropicos de quinolona.
ES8605791A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina
ES8704965A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
ES8703846A1 (es) Un procedimiento para preparar derivados de dihidropiridazi-nona
ES8704872A1 (es) Un procedimiento para preparar aril-hidroxamatos
ES8506612A1 (es) Un metodo para producir un derivado de amina
ES8606879A1 (es) Un procedimiento para la preparacion de derivados esteroida-les
ES8301978A1 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles.
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES8303429A1 (es) Procedimiento para la obtencion de compuestos del acido 7b-amino-tiadiazolilacetilamino-3-amoniometil-3-cefem-4-car-boxilico
ES8404671A1 (es) Un procedimiento para la preparacion de derivados del acido fenoxialquilcarboxilico.
ES8702343A1 (es) Un procedimiento para la produccion de un derivado de diami-das de n-acilaminoacidos
ES8608503A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
ES537133A0 (es) Procedimiento para la obtencion de derivados de acido aroilcarboxilicos de efecto inhibidor de la corrosion
ES8506707A1 (es) Un derivado de acido tiazolilacetico
ES8705224A1 (es) Procedimiento para la obtencion de imidazoles sustituidos
ES8406424A1 (es) Procedimiento para preparar derivados de guanidina.
ES8702385A1 (es) Un procedimiento para preparar un compuesto heterociclico nitrogenado
ES8606260A1 (es) Procedimiento para la obtencion de tioeteres alifaticos
ES8606348A1 (es) Un metodo para preparar un derivado de 9-bencilpurina
ES8604389A1 (es) Procedimientos y compuestos intermedios para preparar derivados de acidos 16-(fenoxi substituido)-prostatrinoicos y sus sales esteroisomeros
ES8607922A1 (es) Procedimiento para preparar 9-oxo-15 a-hidroxi-16-fenoxi y 16-fenoxi sustituido-17,18,19,20-tetranorprosta-4,5,13 (e)- trienoatos
ES8304081A1 (es) "procedimiento para la preparacion de nuevas indolinonas".
ES8505993A1 (es) Un metodo para preparar un derivado de 3-indolcarboxamida

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203